masimo corp. - MASI

MASI

Close Chg Chg %
167.61 3.87 2.31%

Closed Market

171.48

+3.87 (2.31%)

Volume: 350.85K

Last Updated:

Apr 2, 2025, 4:00 PM EDT

Company Overview: masimo corp. - MASI

MASI Key Data

Open

$164.86

Day Range

163.75 - 171.56

52 Week Range

101.61 - 194.88

Market Cap

$9.06B

Shares Outstanding

54.04M

Public Float

49.72M

Beta

1.28

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$5.68

Yield

0.00%

Dividend

$1.00

EX-DIVIDEND DATE

Nov 23, 2012

SHORT INTEREST

N/A

AVERAGE VOLUME

566.47K

 

MASI Performance

1 Week
 
4.85%
 
1 Month
 
-9.16%
 
3 Months
 
0.15%
 
1 Year
 
20.34%
 
5 Years
 
-5.84%
 

MASI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

About masimo corp. - MASI

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. It operates through the following segments: Healthcare and Non-Healthcare. The Healthcare segment develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions and therapeutics. The Non-Healthcare segment designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

MASI At a Glance

Masimo Corp.
52 Discovery
Irvine, California 92618
Phone 1-949-297-7000 Revenue 2.09B
Industry Medical Specialties Net Income -304,900,000.00
Sector Health Technology 2024 Sales Growth 2.261%
Fiscal Year-end 12 / 2025 Employees 9,200
View SEC Filings

MASI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 4.29
Price to Book Ratio 8.591
Price to Cash Flow Ratio 45.753
Enterprise Value to EBITDA 68.549
Enterprise Value to Sales 4.608
Total Debt to Enterprise Value 0.088

MASI Efficiency

Revenue/Employee 227,652.174
Income Per Employee -33,141.304
Receivables Turnover 4.28
Total Asset Turnover 0.739

MASI Liquidity

Current Ratio 1.984
Quick Ratio 1.241
Cash Ratio 0.292

MASI Profitability

Gross Margin 47.956
Operating Margin 1.805
Pretax Margin -14.577
Net Margin -14.558
Return on Assets -10.76
Return on Equity -25.233
Return on Total Capital -16.064
Return on Invested Capital -14.795

MASI Capital Structure

Total Debt to Total Equity 80.435
Total Debt to Total Capital 44.579
Total Debt to Total Assets 32.224
Long-Term Debt to Equity 74.855
Long-Term Debt to Total Capital 41.486
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Masimo Corp. - MASI

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.24B 2.04B 2.05B 2.09B
Sales Growth
+8.34% +64.29% +0.60% +2.26%
Cost of Goods Sold (COGS) incl D&A
430.81M 977.00M 1.04B 1.09B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
36.12M 136.10M 98.30M 103.00M
Depreciation
25.82M 96.30M 43.90M 41.30M
Amortization of Intangibles
10.30M 39.80M 54.40M 61.70M
COGS Growth
+7.52% +126.78% +6.92% +4.35%
Gross Income
808.35M 1.06B 1.00B 1.00B
Gross Income Growth
+8.79% +30.98% -5.22% +0.09%
Gross Profit Margin
+65.23% +52.01% +49.00% +47.96%
2021 2022 2023 2024 5-year trend
SG&A Expense
532.52M 832.20M 839.20M 966.60M
Research & Development
137.23M 191.40M 175.20M 222.80M
Other SG&A
395.29M 640.80M 664.00M 743.80M
SGA Growth
+9.19% +56.27% +0.84% +15.18%
Other Operating Expense
- - - -
-
Unusual Expense
- 16.60M 27.80M 304.50M
EBIT after Unusual Expense
275.82M 210.00M 136.50M (266.70M)
Non Operating Income/Expense
(1.09M) 9.10M 1.90M 5.00M
Non-Operating Interest Income
936.00K 1.80M 3.00M 4.80M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
355.00K 25.70M 50.30M 43.60M
Interest Expense Growth
+5.03% +7,139.44% +95.72% -13.32%
Gross Interest Expense
355.00K 25.70M 50.30M 43.60M
Interest Capitalized
- - - -
-
Pretax Income
274.38M 193.40M 88.10M (305.30M)
Pretax Income Growth
+4.04% -29.51% -54.45% -446.54%
Pretax Margin
+22.14% +9.50% +4.30% -14.58%
Income Tax
44.73M 49.90M 6.60M (400.00K)
Income Tax - Current - Domestic
45.23M 54.80M 18.50M 18.40M
Income Tax - Current - Foreign
14.58M 34.40M 23.70M 19.40M
Income Tax - Deferred - Domestic
(10.94M) (29.20M) (21.50M) (27.30M)
Income Tax - Deferred - Foreign
(4.15M) (10.10M) (14.10M) (10.90M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
229.65M 143.50M 81.50M (304.90M)
Minority Interest Expense
- - - -
-
Net Income
229.65M 143.50M 81.50M (304.90M)
Net Income Growth
-4.43% -37.51% -43.21% -474.11%
Net Margin Growth
+18.53% +7.05% +3.98% -14.56%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
229.65M 143.50M 81.50M (304.90M)
Preferred Dividends
- - - -
-
Net Income Available to Common
229.65M 143.50M 81.50M (304.90M)
EPS (Basic)
4.1628 2.6772 1.5436 -5.7204
EPS (Basic) Growth
-5.24% -35.69% -42.34% -470.59%
Basic Shares Outstanding
55.17M 53.60M 52.80M 53.30M
EPS (Diluted)
3.9813 2.5996 1.5065 -5.7204
EPS (Diluted) Growth
-3.84% -34.70% -42.05% -479.71%
Diluted Shares Outstanding
57.68M 55.20M 54.10M 53.30M
EBITDA
311.94M 362.70M 262.60M 140.80M
EBITDA Growth
+9.59% +16.27% -27.60% -46.38%
EBITDA Margin
+25.17% +17.82% +12.82% +6.72%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 188.571
Number of Ratings 10 Current Quarters Estimate 1.247
FY Report Date 06 / 2025 Current Year's Estimate 5.245
Last Quarter’s Earnings 1.214 Median PE on CY Estimate N/A
Year Ago Earnings 4.40 Next Fiscal Year Estimate 5.886
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 8 8 8
Mean Estimate 1.25 1.27 5.25 5.89
High Estimates 1.29 1.34 5.33 6.26
Low Estimate 1.17 1.22 5.16 5.65
Coefficient of Variance 3.26 2.89 0.90 3.25

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 1 1 1
HOLD 4 4 4
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Masimo Corp. - MASI

Date Name Shares Transaction Value
Mar 17, 2025 Craig B. Reynolds Director 16,581 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $166.13 per share 2,754,601.53
Mar 17, 2025 Bilal Muhsin Chief Operating Officer 7,771 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 17, 2025 Bilal Muhsin Chief Operating Officer 3,512 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Catherine M. Szyman CEO; Director 18,617 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Catherine M. Szyman CEO; Director 8,407 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Micah Young EVP & Chief Financial Officer 7,739 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Micah Young EVP & Chief Financial Officer 3,495 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 17, 2025 Michelle M. Brennan Interim CEO; Director 10,144 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 17, 2025 Michelle M. Brennan Interim CEO; Director 5,328 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $179.51 per share 956,429.28
Feb 17, 2025 Michelle M. Brennan Interim CEO; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 6, 2024 Craig B. Reynolds Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 2, 2024 Craig B. Reynolds Director 10,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Masimo Corp. in the News